Inventor · disambiguated record
Anne North
Also filed as: NORTH ANNE · NORTH ANNE K
5 granted patents·5 pending applications·50 citations·filing 1998–2025
79Inventor score
Top patents by PatentIndex Score
10 records- 0190US10357516B2Pathogen-inactivated red blood cell compositionsCERUS CORP·Filed 2017·Granted Jul 23, 2019·13 cites·22 claims
- 0289US9713627B2Pathogen-inactivated red blood cell compositionsCERUS CORP·Filed 2014·Granted Jul 25, 2017·15 cites·27 claims
- 0386US8900805B2Quenching methods for red blood cell pathogen inactivationMUFTI NAHEED·Filed 2009·Granted Dec 2, 2014·20 cites·77 claims
- 0481US12282015B2Systems and methods for testing and screening using compound bound substratesCERUS CORP·Filed 2023·Granted Apr 22, 2025·0 cites·10 claims
- 0575US2025216379A1Systems and methods for testing and screening using compound bound substratesCERUS CORP·Filed 2025·Application pending·0 cites
- 0661US2019369087A1Systems and methods for testing and screening using compound bound substratesCERUS CORP·Filed 2017·Application pending·0 cites
- 0749US2022031917A1Methods and kits for preparing pathogen-inactivated whole bloodCERUS CORP·Filed 2019·Application pending·0 cites
- 0844US2003203464A1Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activityFiled 2002·Application pending·0 cites
- 0935US6340575B1Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activityONYX PHARMA INC·Filed 1998·Granted Jan 22, 2002·2 cites·15 claims
- 1027US2003013181A1Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidaseFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →